These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 21920451

  • 1. Small peptides derived from somatotropin domain-containing proteins inhibit blood and lymphatic endothelial cell proliferation, migration, adhesion and tube formation.
    Lee E, Rosca EV, Pandey NB, Popel AS.
    Int J Biochem Cell Biol; 2011 Dec; 43(12):1812-21. PubMed ID: 21920451
    [Abstract] [Full Text] [Related]

  • 2. Synergy between a collagen IV mimetic peptide and a somatotropin-domain derived peptide as angiogenesis and lymphangiogenesis inhibitors.
    Koskimaki JE, Lee E, Chen W, Rivera CG, Rosca EV, Pandey NB, Popel AS.
    Angiogenesis; 2013 Jan; 16(1):159-70. PubMed ID: 23053781
    [Abstract] [Full Text] [Related]

  • 3. Sunitinib inhibits lymphatic endothelial cell functions and lymph node metastasis in a breast cancer model through inhibition of vascular endothelial growth factor receptor 3.
    Kodera Y, Katanasaka Y, Kitamura Y, Tsuda H, Nishio K, Tamura T, Koizumi F.
    Breast Cancer Res; 2011 Jun 21; 13(3):R66. PubMed ID: 21693010
    [Abstract] [Full Text] [Related]

  • 4. Aspirin suppresses components of lymphangiogenesis and lymphatic vessel remodeling by inhibiting the NF-κB/VCAM-1 pathway in human lymphatic endothelial cells.
    Prangsaengtong O, Jantaree P, Lirdprapamongkol K, Ngiwsara L, Svasti J, Koizumi K.
    Vasc Med; 2018 Jun 21; 23(3):201-211. PubMed ID: 29629844
    [Abstract] [Full Text] [Related]

  • 5. A heparin conjugate, LHbisD4, inhibits lymphangiogenesis and attenuates lymph node metastasis by blocking VEGF-C signaling pathway.
    Choi JU, Chung SW, Al-Hilal TA, Alam F, Park J, Mahmud F, Jeong JH, Kim SY, Byun Y.
    Biomaterials; 2017 Sep 21; 139():56-66. PubMed ID: 28586719
    [Abstract] [Full Text] [Related]

  • 6. Targeting VEGFR-3/-2 signaling pathways with AD0157: a potential strategy against tumor-associated lymphangiogenesis and lymphatic metastases.
    García-Caballero M, Paupert J, Blacher S, Van de Velde M, Quesada AR, Medina MA, Noël A.
    J Hematol Oncol; 2017 Jun 19; 10(1):122. PubMed ID: 28629427
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of breast cancer growth and metastasis by a biomimetic peptide.
    Lee E, Lee SJ, Koskimaki JE, Han Z, Pandey NB, Popel AS.
    Sci Rep; 2014 Nov 20; 4():7139. PubMed ID: 25409905
    [Abstract] [Full Text] [Related]

  • 8. Lamstatin--a novel inhibitor of lymphangiogenesis derived from collagen IV.
    Weckmann M, Moir LM, Heckman CA, Black JL, Oliver BG, Burgess JK.
    J Cell Mol Med; 2012 Dec 20; 16(12):3062-73. PubMed ID: 22998238
    [Abstract] [Full Text] [Related]

  • 9. Growth hormone promotes lymphangiogenesis.
    Banziger-Tobler NE, Halin C, Kajiya K, Detmar M.
    Am J Pathol; 2008 Aug 20; 173(2):586-97. PubMed ID: 18583315
    [Abstract] [Full Text] [Related]

  • 10. Phomaketide A Inhibits Lymphangiogenesis in Human Lymphatic Endothelial Cells.
    Tai HC, Lee TH, Tang CH, Chen LP, Chen WC, Lee MS, Chen PC, Lin CY, Chi CW, Chen YJ, Lai CT, Chen SS, Liao KW, Lee CH, Wang SW.
    Mar Drugs; 2019 Apr 06; 17(4):. PubMed ID: 30959907
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of lymphangiogenesis and angiogenesis in breast tumor xenografts and lymph nodes by a peptide derived from transmembrane protein 45A.
    Lee E, Koskimaki JE, Pandey NB, Popel AS.
    Neoplasia; 2013 Feb 06; 15(2):112-24. PubMed ID: 23441126
    [Abstract] [Full Text] [Related]

  • 12. Suppression of lymphangiogenesis in human lymphatic endothelial cells by simultaneously blocking VEGF-C and VEGF-D/VEGFR-3 with norcantharidin.
    Liu ZY, Qiu HO, Yuan XJ, Ni YY, Sun JJ, Jing W, Fan YZ.
    Int J Oncol; 2012 Nov 06; 41(5):1762-72. PubMed ID: 22922710
    [Abstract] [Full Text] [Related]

  • 13. Nucleoside/nucleotide reverse transcriptase inhibitors attenuate angiogenesis and lymphangiogenesis by impairing receptor tyrosine kinases signalling in endothelial cells.
    Song L, Ding S, Ge Z, Zhu X, Qiu C, Wang Y, Lai E, Yang W, Sun Y, Chow SA, Yu L.
    Br J Pharmacol; 2018 Apr 06; 175(8):1241-1259. PubMed ID: 28910489
    [Abstract] [Full Text] [Related]

  • 14. A potential small-molecule synthetic antilymphangiogenic agent norcantharidin inhibits tumor growth and lymphangiogenesis of human colonic adenocarcinomas through blocking VEGF-A,-C,-D/VEGFR-2,-3 "multi-points priming" mechanisms in vitro and in vivo.
    Li XP, Jing W, Sun JJ, Liu ZY, Zhang JT, Sun W, Zhu W, Fan YZ.
    BMC Cancer; 2015 Jul 19; 15():527. PubMed ID: 26187792
    [Abstract] [Full Text] [Related]

  • 15. Corosolic Acid Exhibits Anti-angiogenic and Anti-lymphangiogenic Effects on In Vitro Endothelial Cells and on an In Vivo CT-26 Colon Carcinoma Animal Model.
    Yoo KH, Park JH, Lee DY, Hwang-Bo J, Baek NI, Chung IS.
    Phytother Res; 2015 May 19; 29(5):714-23. PubMed ID: 25644809
    [Abstract] [Full Text] [Related]

  • 16. A small molecular agent YL529 inhibits VEGF-D-induced lymphangiogenesis and metastasis in preclinical tumor models in addition to its known antitumor activities.
    Xu Y, Lu W, Yang P, Peng W, Wang C, Li M, Li Y, Li G, Meng N, Lin H, Kan L, Wang S, Yang S, Yu L, Zhao Y.
    BMC Cancer; 2015 Jul 18; 15():525. PubMed ID: 26187637
    [Abstract] [Full Text] [Related]

  • 17. Tumour necrosis factor superfamily member 15 (Tnfsf15) facilitates lymphangiogenesis via up-regulation of Vegfr3 gene expression in lymphatic endothelial cells.
    Qin TT, Xu GC, Qi JW, Yang GL, Zhang K, Liu HL, Xu LX, Xiang R, Xiao G, Cao H, Wei Y, Zhang QZ, Li LY.
    J Pathol; 2015 Nov 18; 237(3):307-18. PubMed ID: 26096340
    [Abstract] [Full Text] [Related]

  • 18. The tyrosine kinase inhibitor cediranib blocks ligand-induced vascular endothelial growth factor receptor-3 activity and lymphangiogenesis.
    Heckman CA, Holopainen T, Wirzenius M, Keskitalo S, Jeltsch M, Ylä-Herttuala S, Wedge SR, Jürgensmeier JM, Alitalo K.
    Cancer Res; 2008 Jun 15; 68(12):4754-62. PubMed ID: 18559522
    [Abstract] [Full Text] [Related]

  • 19. Liposomal honokiol inhibits VEGF-D-induced lymphangiogenesis and metastasis in xenograft tumor model.
    Wen J, Fu AF, Chen LJ, Xie XJ, Yang GL, Chen XC, Wang YS, Li J, Chen P, Tang MH, Shao XM, Lu Y, Zhao X, Wei YQ.
    Int J Cancer; 2009 Jun 01; 124(11):2709-18. PubMed ID: 19219913
    [Abstract] [Full Text] [Related]

  • 20. The Role of Methionine Aminopeptidase 2 in Lymphangiogenesis.
    Esa R, Steinberg E, Dror D, Schwob O, Khajavi M, Maoz M, Kinarty Y, Inbal A, Zick A, Benny O.
    Int J Mol Sci; 2020 Jul 21; 21(14):. PubMed ID: 32708166
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.